EP
CLB icon

Essential Partners’s Core Laboratories CLB Stock Holding History

Essential Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839 Sell
72
-50
-41% -$714 ﹤0.01% 2317
2026
Q1 		$2.05K Hold
122
– – ﹤0.01% 1999
2025
Q4 		$1.96K Buy
122
+82
+205% +$1.22K ﹤0.01% 1808
2025
Q3 		$494 Buy
+40
New +$469 ﹤0.01% 2207

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Essential Partners's CLB Position: Q2 2026 in Review

Essential Partners reduced its Core Laboratories (CLB) stake by 41% in Q2 2026, selling an estimated $714 and leaving 72 shares worth $839. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

Essential Partners first reported a position in CLB in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.05K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Essential Partners held 72 shares of Core Laboratories worth $839 as of Q2 2026.
  • Essential Partners sold 50 Core Laboratories shares in Q2 2026, an estimated $714.
  • Core Laboratories made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2317 holding.
  • Essential Partners first reported a position in Core Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Core Laboratories position peaked at $2.05K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.